FIELD: medicine.
SUBSTANCE: invention relates to application of compositions for local application which contain epidermal growth factor. Invention is aimed at application of efficient amount of epidermal growth factor, incapsulated or bound with deformable or ordinary liposomes, for production of pharmaceutical composition for local application for treatment of diabetic foot ulcers of IV and V severity degree in patients with diabetes.
EFFECT: invention ensures high EGF bioavailability in tissues deeply lower than affection nodes and allows to prevent amputation caused by diabetic foot.
8 cl, 8 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| USING PHARMACEUTICAL COMPOSITION COMPRISING EPIDERMAL GROWTH FACTOR (EGF) FOR PREVENTION OF DIABETIC LIMB AMPUTATION | 2002 |
|
RU2289424C2 |
| VESICLES COMPRISING EPIDERMAL GROWTH FACTOR AND COMPOSITIONS THEREOF | 2013 |
|
RU2649781C2 |
| PHARMACEUTICAL COMPOSITION IN FORM OF MICROSPHERES FOR PREVENTION OF EXTREMITY AMPUTATION IN CASE OF DIABETES | 2007 |
|
RU2426528C2 |
| LIPID NANOPARTICLES FOR HEALING WOUNDS | 2014 |
|
RU2662097C2 |
| NANOLIPOSOME WITH APPLICATION OF ETHERIFICATED LECITIN AND METHOD OF OBTAINING SUCH, AS WELL AS COMPOSITION FOR PREVENTION OR TREATMENT OF SKIN DISEASES INCLUDING SUCH LIPOSOMES | 2007 |
|
RU2418575C2 |
| APPLICATION OF PHARMACEUTICAL COMPOSITIONS IN MANUFACTURING MEDICATIONS FOR TREATMENT OF DIABETIC ULCERS | 2010 |
|
RU2523889C2 |
| APPLICATION OF EPIDERMAL GROWTH FACTOR FOR MORPHOFUNCTIONAL RECOVERY OF PERIPHERAL NERVES IN DIABETIC NEUROPATHY | 2007 |
|
RU2460536C2 |
| METHOD OF TREATING DIABETIC FOOT ULCERS, PRESSURE ULCERS, VENOUS LEG ULCERS AND ASSOCIATED COMPLICATIONS | 2013 |
|
RU2664710C2 |
| COMPOSITIONS COMPRISING COCKTAILS OF ANTIBACTERIAL PHAGES AND USES THEREOF | 2013 |
|
RU2654596C2 |
| METHOD OF TREATING DEFECTS OF SKIN AND SOFT TISSUES IN PATIENTS WITH DIABETES MELLITUS AND METHOD OF INTRODUCTION OF DRUG THEREFOR | 2017 |
|
RU2679449C1 |
